Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2013-05-01 COX GEOFFREY F Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2013-05-01 Cook Peter Chapman Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2013-05-01 VANLENT ANNE Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2013-05-01 DOUGHERTY MICHAEL R Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2012-11-12 PLUMB RUSSELL H CEO & President Grant or award +143,322 143,322
2012-11-12 PLUMB RUSSELL H CEO & President Grant or award · Stock Option (Right to Buy) +573,286 573,286
2012-11-12 PATTI JOSEPH M EVP, Corporate Dev & Strategy Grant or award +71,661 71,661
2012-11-12 PATTI JOSEPH M EVP, Corporate Dev & Strategy Grant or award · Stock Option (Right to Buy) +358,304 358,304
2012-04-05 Kessler Paul D. SVP Clinical, Med. & Reg.; CMO Sale −5,167 $1.90 $10K 105,128
2011-05-25 DAVIS PETER B Director Grant or award · Stock Option (right to buy) +20,000 20,000
2011-05-25 CASTALDI DAVID L Director Grant or award · Stock Option (right to buy) +20,000 20,000
2011-05-25 LYNCH TIMOTHY P Director Grant or award · Stock Option (right to buy) +20,000 20,000
2011-05-25 HARVEY RICHARD A JR Director Grant or award · Stock Option (right to buy) +20,000 20,000
2011-05-25 COX GEOFFREY F Director Grant or award · Stock Option (right to buy) +40,000 40,000
2011-05-25 Aryeh Jason Director Grant or award · Stock Option (right to buy) +20,000 20,000
2011-05-16 Kessler Paul D. SVP Clinical, Med. & Reg.; CMO Sale −7,500 $5.53 $41K 115,171
2011-05-16 Kessler Paul D. SVP Clinical, Med. & Reg.; CMO Sale −4,876 $5.48 $27K 110,295
2011-04-05 FAHIM RAAFAT E F President, CEO and CFO Sale −13,283 $5.76 $76K 373,473.94
2011-04-05 Kessler Paul D. SVP Clinical, Med. & Reg.; CMO Sale −8,596 $5.76 $49K 122,671
2011-04-01 FAHIM RAAFAT E F President, CEO and CFO Grant or award +50,000 386,756.94

Page 26 of 42 · 830 trades